| Direct Competitor Comparison | |
|---|
| OREX | ABT | GSK | RHHBY | Industry |
|---|
| Market Cap: | 599.08M | 58.81B | 128.12B | 222.98B | 32.64B |
|---|
| Employees: | 41 | 91,000 | 99,488 | 82,089 | 35.15k |
|---|
| Qtrly Rev Growth (yoy): | 0.00 | 0.02 | -0.03 | 0.12 | 1.74 |
|---|
| Revenue (ttm):
| 3.43M | 39.97B | 42.21B | 50.83B | 13.93B |
|---|
| Gross Margin (ttm): | N/A | 0.62 | 0.71 | 0.75 | 0.83 |
|---|
| EBITDA (ttm): | -98.88M | 11.56B | 14.49B | 20.10B | 5.72B |
|---|
| Operating Margin (ttm):
| -28.93 | 0.22 | 0.28 | 0.34 | 0.20 |
|---|
| Net Income (ttm): | -99.05M | 6.11B | 6.78B | 10.22B | N/A |
|---|
| EPS (ttm): | -1.29 | 3.28 | 2.74 | 2.99 | 2.00 |
|---|
| P/E (ttm): | N/A | 11.51 | 19.33 | 21.99 | 24.04 |
|---|
| PEG (5 yr expected): | -0.51 | 1.48 | 4.17 | 2.29 | 1.15 |
|---|
| P/S (ttm): | 178.90 | 1.46 | 3.03 | 4.38 | 3.04 |
|---|
|
| ABT = Abbott Laboratories | | GSK = GlaxoSmithKline plc | | RHHBY = Roche Holding AG | | Industry = Drug Manufacturers - Other | |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 105.39 | -0.00 | 79.04B | 17.84 |
|---|
| Genentech, Inc. | "Private" |
|---|
| Biogen Idec Inc. | BIIB | 233.15 | 0.00 | 55.34B | 37.00 |
|---|
| Genzyme Corporation | "Private" |
|---|
| Merck Serono S.A. | "Private" |
|---|
| Gilead Sciences Inc. | GILD | 55.94 | 0.01 | 85.04B | 31.32 |
|---|
| MedImmune, L.L.C. | "Private" |
|---|
| Life Technologies Corporation | LIFE | 73.86 | -0.00 | 12.71B | 31.27 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 39.23 | -0.01 | 33.35B | 19.59 |
|---|
| Sandoz International GmbH | "Private" |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 126.61 | -0.01 | 16.21B | N/A |
|---|
| Ranbaxy Laboratories Limited | "Private" |
|---|
| Mylan, Inc. | MYL | 31.38 | -0.01 | 11.92B | 20.96 |
|---|
| Pfizer Inc. | PFE | 29.05 | -0.00 | 206.31B | 13.91 |
|---|
| Johnson & Johnson | JNJ | 86.82 | -0.00 | 243.90B | 23.58 |
|---|
| GlaxoSmithKline plc | GSK | 52.89 | 0.00 | 128.12B | 19.33 |
|---|
| Sanofi | SNY | 54.69 | 0.00 | 144.49B | 26.95 |
|---|
| Novartis AG | NVS | 74.05 | 0.00 | 181.96B | 18.79 |
|---|
| Roche Holding AG | RHHBY | 65.70 | 0.00 | 222.98B | 21.99 |
|---|
| AstraZeneca PLC | AZN | 52.04 | -0.00 | 65.00B | 11.51 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 37.76 | 0.01 | 58.81B | 11.51 |
|---|
| Bristol-Myers Squibb Company | BMY | 46.71 | -0.01 | 76.72B | 52.90 |
|---|
|
| News on Direct Competitors | |
|---|
- GSK
- Spinning RECORD: Battle Over Rosiglitazone Heats Up Two Weeks Before Crucial FDA Meeting at Forbes Fri 9:46am
- GSK
- Glaxo Alleges Errors In Nissen's Critique Of FDA's Handling Of Avandia at Forbes Thu 9:23pm
- GSK
- German, French Indices Vulnerable at Elevated Levels at Motley Fool Thu 5:56pm
- GSK
- Impax Launches Generic Zomig Zacks Thu 5:40pm
- ABT
- Follow The 'Smart Money' And Buy Johnson & Johnson In The Next Pullback at Seeking Alpha Thu 3:48pm
- ABT
- BSX, ABT, ZMH, and ETRM Under StockCall’s Microscope Accesswire Thu, May 2
- GSK
- GSK, AZN, KERX, and RPTP Early Briefing and Review Accesswire Thu, May 2
- RHHBY
- News And Analysis Reports On: (OTCQX: RHHBY), (OTC Pink: NSRGY) Accesswire Mon, Apr 22
- RHHBY
- Petro Bakken Energy Ltd. And Roche Holding Ltd. Reports: (OTC Pink: PBKEF), (OTCQX: RHHBY) Accesswire Thu, Apr 18
- ABT
- Analysis: Big Pharma down, not out, after Indian patent blow Reuters Tue, Apr 2
- ABT
- AbbVie seeks to stop EU agency releasing drug data Reuters Sun, Mar 10
- RHHBY
- Pacific Therapeutics Ltd. Issues Stock Options to Directors and Officers Accesswire Fri, Dec 21
- RHHBY
- Penny Stocks Watch-List Traders Should Be Aware Of: (OTCQB: KWBT), (OTCQB: RHHBY) Accesswire Mon, Dec 3
- ABT
- News Recap: Google Inc, Pacwest Equities Inc, Abbott Laboratories, eBay Inc, Clearwire Corporation Accesswire Thu, Oct 18
- RHHBY
- Breast Cancer News: Geron Drug Fails, Herceptin® May Increase Heart Problems, Sunshine Biopharma Heading for Clinical Trials Accesswire Thu, Sep 20
All headlines for these symbols... Currency in USD. | |
|
0.15(2.31%) 12:23PM EDT - Nasdaq Real Time Price